Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-16-664025
Filing Date
2016-07-29
Accepted
2016-07-29 13:14:58
Documents
9
Period of Report
2016-07-29

Document Format Files

Seq Description Document Type Size
1 6-K d231911d6k.htm 6-K 15613
2 EX-99.1 d231911dex991.htm EX-99.1 826968
3 EX-99.2 d231911dex992.htm EX-99.2 28555
4 EX-99.3 d231911dex993.htm EX-99.3 13922
5 EX-99.4 d231911dex994.htm EX-99.4 30559
6 EX-99.5 d231911dex995.htm EX-99.5 42302
7 GRAPHIC g231911dsp05.jpg GRAPHIC 3561
8 GRAPHIC g231911dsp33.jpg GRAPHIC 3805
9 GRAPHIC g231911dsp39.jpg GRAPHIC 4222
  Complete submission text file 0001193125-16-664025.txt   975444
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 161793176
SIC: 2834 Pharmaceutical Preparations